O6.05 ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA

BACKGROUND: While EGFRvIII appears a logical target for immunotherapy, only a subpopulation of tumor cells express EGFRvIII and immune escape has been demonstrated. ErbB2 is overexpressed in a substantial proportion of glioblastomas and has been successfully utilized in immunotherapies. Natural kill...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Burger, M.C., Zhang, C., Jennewein, L., Schönfeld, K., Genßler, S., Grez, M., Tonn, T., Mittelbronn, M., Steinbach, J.P., Wels, W.S.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Oral Presentations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185813/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.46
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items